SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-21-007937
Filing Date
2021-02-10
Accepted
2021-02-10 08:21:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A ea135079-defa14a_neo.htm DEFA14A 25367
  Complete submission text file 0001213900-21-007937.txt   26364
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Filer) CIK: 0001467652 (see all company filings)

IRS No.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37508 | Film No.: 21609371
SIC: 2834 Pharmaceutical Preparations